|
Name |
[(3R,4aS,6R)-3,4'-dihydroxy-1,1,4a,6-tetramethyl-6'-oxospiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2'-7,8-dihydro-3H-furo[2,3-e]isoindole]-2-yl] acetate
|
Molecular Formula | C25H33NO6 | |
IUPAC Name* |
[(3R,4aS,6R)-3,4'-dihydroxy-1,1,4a,6-tetramethyl-6'-oxospiro[3,4,6,7,8,8a-hexahydro-2H-naphthalene-5,2'-7,8-dihydro-3H-furo[2,3-e]isoindole]-2-yl] acetate
|
|
SMILES |
C[C@@H]1CCC2[C@@](C13CC4=C(C=C5C(=C4O3)CNC5=O)O)(C[C@H](C(C2(C)C)OC(=O)C)O)C
|
|
InChI |
InChI=1S/C25H33NO6/c1-12-6-7-19-23(3,4)21(31-13(2)27)18(29)10-24(19,5)25(12)9-15-17(28)8-14-16(20(15)32-25)11-26-22(14)30/h8,12,18-19,21,28-29H,6-7,9-11H2,1-5H3,(H,26,30)/t12-,18-,19?,21?,24+,25?/m1/s1
|
|
InChIKey |
JOLITHWHEFIGDT-OYTJFVJTSA-N
|
|
Synonyms |
Chartarlactam K
|
|
CAS | NA | |
PubChem CID | 102362354 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 443.5 | ALogp: | 3.3 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 105.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 32 | QED Weighted: | 0.569 |
Caco-2 Permeability: | -4.968 | MDCK Permeability: | 0.00000706 |
Pgp-inhibitor: | 0.024 | Pgp-substrate: | 0.99 |
Human Intestinal Absorption (HIA): | 0.044 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.009 |
Blood-Brain-Barrier Penetration (BBB): | 0.174 | Plasma Protein Binding (PPB): | 95.33% |
Volume Distribution (VD): | 0.956 | Fu: | 13.99% |
CYP1A2-inhibitor: | 0.075 | CYP1A2-substrate: | 0.273 |
CYP2C19-inhibitor: | 0.034 | CYP2C19-substrate: | 0.377 |
CYP2C9-inhibitor: | 0.336 | CYP2C9-substrate: | 0.9 |
CYP2D6-inhibitor: | 0.771 | CYP2D6-substrate: | 0.317 |
CYP3A4-inhibitor: | 0.325 | CYP3A4-substrate: | 0.323 |
Clearance (CL): | 10.183 | Half-life (T1/2): | 0.382 |
hERG Blockers: | 0.026 | Human Hepatotoxicity (H-HT): | 0.437 |
Drug-inuced Liver Injury (DILI): | 0.434 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.843 | Maximum Recommended Daily Dose: | 0.929 |
Skin Sensitization: | 0.34 | Carcinogencity: | 0.043 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.044 |
Respiratory Toxicity: | 0.905 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005397 | 0.802 | D0D2TN | 0.290 | ||||
ENC001975 | 0.785 | D04SFH | 0.270 | ||||
ENC003017 | 0.785 | D09WYX | 0.268 | ||||
ENC003009 | 0.785 | D0X7XG | 0.265 | ||||
ENC003020 | 0.708 | D0KR5B | 0.264 | ||||
ENC002673 | 0.708 | D0D1SG | 0.264 | ||||
ENC005396 | 0.708 | D0P0HT | 0.262 | ||||
ENC003012 | 0.644 | D02JNM | 0.261 | ||||
ENC002009 | 0.644 | D0I2SD | 0.260 | ||||
ENC002994 | 0.640 | D08PIQ | 0.260 |